title: Bioresorbable scaffolds for the treatment of in-stent restenosis.
abstract: Percutaneous coronary intervention with bare-metal stents or drug-eluting stents can decrease clinical event rates compared with simple balloon angioplasty. However, stent implantation is often associated with subsequent restenosis. Bioresorbable coronary scaffolds provide short-term vessel scaffolding with drug delivery capability and are designed to avoid the long-term limitations of metallic stents such as late stent thrombosis and in-stent restenosis. To the best of our knowledge, we report the first case series of successful treatment of in-stent restenosis using bioresorbable scaffolds.
authors.affiliation: Department of Cardiology, University of Giessen, Klinikstr. 33, 35392, Giessen, Germany, oliver.doerr@innere.med.uni-giessen.de.
authors.forename: Oliver
authors.initials: O
authors.lastname: Dörr
authors.forename: Christoph
authors.initials: C
authors.lastname: Liebetrau
authors.forename: Jens
authors.initials: J
authors.lastname: Wiebe
authors.forename: Franziska
authors.initials: F
authors.lastname: Hecker
authors.forename: Johannes
authors.initials: J
authors.lastname: Rixe
authors.forename: Helge
authors.initials: H
authors.lastname: Möllmann
authors.forename: Christian
authors.initials: C
authors.lastname: Hamm
authors.forename: Holger
authors.initials: H
authors.lastname: Nef
mesh_terms: D020341:Absorbable Implants; D000368:Aged; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation*; D011474:Prosthesis Design; D015607:Stents; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome